Table 1. Overview of different angiogenic factors and their correlation with STS prognosis.
Category | Major functions | Names | Correlation with prognosis | Reference(s) |
---|---|---|---|---|
Angiogenesis inducers | Induction of EC (endothelial cell) growth, proliferation and survival under stress; induction of migration of ECs during sprouting angiogenesis; increase vascular permeability of ECs; stimulate secretion of proteinases important for tumour invasion and progression; activate matrix degrading enzymes (e.g. metalloproteinases); recruitment of tissue infiltrating hematopoietic cells, modulates receptor-ligand interaction. HIF-1α and angiogenin are transcriptional controller of many of the factors indicated | VEGF-A | + | [8,9,50] |
VEGF-B | + | [8,10] | ||
VEGF-C | + | [8,11] | ||
VEGF-D | − | [8] | ||
FGF-1 | − | [12] | ||
FGF-2 | + | [13,55] | ||
PDGF | + | [9,14,15,55] | ||
PlGF | + | [8,16] | ||
IGF-I/II | − | [17] | ||
Ang-1 | − | [18] | ||
EGF | + | [11,19] | ||
HGF | + | [20,21] | ||
HIF-1α | + | [11,22] | ||
TGF-α | − | [23] | ||
TGF-β | + | [24,25] | ||
TNF-α | − | [26] | ||
IL-1 | − | [27] | ||
IL-8 | + | [28] | ||
NP1/2 | − | [29] | ||
Angiogenin | − | [30] | ||
SDF-1 | − | [31] | ||
Angiogenesis inhibitors | Inhibition of ECs proliferation and growth and induction of ECs apoptosis; inhibit ion of ECs migration and blood vessels maturation; inhibition of the metalloproteinases activity or uPa activity | TSP-1/2 | − | [32,33] |
Angiostatin | − | [34] | ||
Endostatin | + | [35,36] | ||
Vasostatin | − | [37] | ||
PF-4 | − | [38] | ||
Antiangiogenic Antithrombin III | − | [39] | ||
TIMPs | + | [40–43] | ||
Ang-2 | − | [44,45] |